AvidBiotics' Series B Round

AvidBiotics raised a round of funding on January 23, 2008.

AvidBiotics is a developer of non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancers. The scaffolds of AvidBiotics' proteins exhibit functional potency, e.g. kil…

Articles about AvidBiotics' Series B Round: